National Center for Antimicrobials and Infection Control, Statens Serum Institut, Copenhagen S, Denmark.
J Infect. 2010 Mar;60(3):191-9. doi: 10.1016/j.jinf.2009.12.007. Epub 2009 Dec 22.
A population-based nested case-control study was conducted in order to characterize patient factors and microbial species associated with recurrent bacteraemia.
All patients with bacteraemia in a Danish region during 1996-2006 were investigated. Recurrence was defined based on pathogen identity, site of infection and time frame, and not restricted to homologous pathogens.
We identified 8672 patients with first-time bacteraemia, of whom 1003 (12%) had a recurrence within 1 year. The proportion of mono-microbial bacteraemia was similar for first (86%) and recurrent episodes (84%). An unknown focus was common in both episodes (22.7 and 29.1%, respectively). Independent predictors of a recurrence (incidence rate ratio, 95% confidence interval) included health care-associated (2.4; 1.9-3.0) and nosocomial bacteraemia (2.1; 1.8-2.6), poly-microbial Gram-positive bacteraemia (2.7; 1.6-4.6), and fungaemia (2.2; 1.4-3.5), a Charlson co-morbidity index score of 1-2 (1.7; 1.4-2.1), inappropriate empirical antimicrobial chemotherapy (1.3; 1.1-1.5), a gastro-intestinal tract focus (2.3; 1.7-3.0), a liver/biliary tract focus (2.7; 2.0-3.6), an iv-catheter focus (2.0; 1.4-2.8), endocarditis (2.7; 1.6-4.3), and an unknown focus (1.9; 1.5-2.3).
This study showed recurrent bacteraemia to be common and the following risk factors were identified: a health care-associated or nosocomial origin, poly-microbial or fungal aetiology, a focus within the abdomen, endocardium, iv-catheter-related or unknown, a Charlson co-morbidity index score of >1 and inappropriate empirical antimicrobial chemotherapy.
为了描述与复发性菌血症相关的患者因素和微生物种类,我们进行了一项基于人群的巢式病例对照研究。
我们调查了丹麦一个地区在 1996-2006 年期间所有发生菌血症的患者。复发的定义基于病原体的身份、感染部位和时间范围,而不限于同源病原体。
我们确定了 8672 例首次菌血症患者,其中 1003 例(12%)在 1 年内复发。首次和复发性感染中单一微生物菌血症的比例相似(分别为 86%和 84%)。两个阶段都常见未知病灶(分别为 22.7%和 29.1%)。复发的独立预测因素(发病率比,95%置信区间)包括与医疗保健相关(2.4;1.9-3.0)和医院获得性菌血症(2.1;1.8-2.6)、多微生物革兰氏阳性菌血症(2.7;1.6-4.6)和真菌感染(2.2;1.4-3.5)、Charlson 合并症指数评分 1-2 分(1.7;1.4-2.1)、经验性抗菌治疗不当(1.3;1.1-1.5)、胃肠道病灶(2.3;1.7-3.0)、肝脏/胆道病灶(2.7;2.0-3.6)、静脉导管病灶(2.0;1.4-2.8)、心内膜炎(2.7;1.6-4.3)和未知病灶(1.9;1.5-2.3)。
本研究表明复发性菌血症较为常见,以下为危险因素:医疗保健相关或医院获得性来源、多微生物或真菌感染、腹部、心内膜、静脉导管相关或未知部位的病灶、Charlson 合并症指数评分>1 分和经验性抗菌治疗不当。